Skip to main content
. 2024 Jan 30;16(1):e53217. doi: 10.7759/cureus.53217

Figure 2. Newly diagnosed AML treatment flowchart.

Figure 2

Azacitidine (Aza); venetoclax (ven); 7 + 3 refers to seven days of cytarabine with three concurrent days of an anthracycline; high-dose cytarabine (HiDAC); hematopoietic stem cell transplant (HSCT); fludarabine cytarabine idarubicin and G-CSF (FLAG-IDA); mitoxantrone etoposide cytarabine (MEC).